Migeon e t a 1 (1968) d e s c r i b e d an e n t i t y of a d r e n a l unresponsiven e s s t o ACTH c h a r a c t e r i z e d by hypoglycemia,hyperpigmentation normal t o l e r a n c e t o s a l t d e p r i v a t i o n and no e l e v a t i o n o f plasma cort i s o l with ACTII. The possibility of X-linked and autosomal forms s u g g e s t s h e t e r o g e n e i t y i n t h i s r a r e c o n d i t i o n . Two a f f e c t e d brothe r s , o f f s p r i n g of f i r s t -c o u s i n p a r e n t s a r e p r e s e n t e d . The f i r s t c a s e d i e d a t t h e age of t h r e e y e a r s of "unknown cause" with a h i s t o r y o f i n t e r m i t t e n t hypoglycemia p r e c i p i t a t e d by t h e s t r e s s of i n f e c t i o n s . Post-mortem exammation r e v e a l e d marked hypcrpigmentat i o n , c e r e b r a l edema, s m a l l f o c i of c a l c i f i c a t i o n s s c a t t e r e d i n t h e a r t e r i o l a r wall. The a d r e n a l s were h y p o p l a s t i c showing degcne r a t i o n of t h c zona f a s c i c u l a t a and r c t i c u l a r i s , with p r e s e r v a t i o n of t h e zona glomerulosa. The second son s t a r t e d with s i m i l a r s i g n s and symptoms a t i h c agc o f two y e a r s and a l s o showed hyperpigment a t i o n when he was admitted t o t h e Pediatric S e r v i c e of t h e Univers i t y o f B r a s i l i a , s i x months l a t e r . Laboratory i n v e s t i g a t i o n r evealed 28mg96 g l u c o s e , 1 3 6 m~~/ l sodium, 4,lm!q/l potassium,calcium, phosphorus, u r i c a c i d , a l k a l i n e phosphatase, c o l c s t e r o l , t r i g l yc e r i d e s were within normal range. h d o c r i n e t e s t i n g showed normal IIGII, PRL, T3, T4, E l l r e s p o n s e s . The c o r t i s o l l e v e l s were undetecta b l e even a f t c r s i x hours I V ACTH a d m i n i s t r a t i o n . The p a t i c n t was p u t i n a r e g u l a r d i e t with prednlsonc 2,5mg t w i c e d a i l y and is q u i t e w e l l on t h i s regimen. Approximately 10-20% o f the prolactinomas a r e recognized b e f o r e age 20. However, t h e r e a r e few r e p o r t s on t h e i r medium and l o n g term follow-up.
T h i r t e e n p a t i e n t s ( B ? . 9i') aged 14.2 -20 y r . ( X 16.5 y r ) w i t h prolactinoma were f o l l o w e d f o r 9 m-12 y r . Headaches, impairment of p u b e r t a l development, galactorrhea and v i s u a l f i e l d defects were the most comnon c l i n i c a l findings. The responses of LH and FSH t o LH-RH among p a t i e n t s v a n e d from normal, exaggerated o r absent. THe TRH (TSH) t e s t was normal i n 819 cases and i n I $ a primary concomitant hypothyroidism was reported.
Serum PRL was elevated i n a l l P a l i e n t s ranging 77-1150 nglml (X 3782285). PRL r e sponse a f t e r TRH was inadequate (X A MAX:25%). R a d i o l o g i c a l l y , t h e p a t i e n t s were c l a s s i f i e d (Vezina and Sutton) i n GI: n=3 ( 0 1; G2: n=5 ( 4 ? . ld); 63: n=3 ( 1 9 .
2 6 ) and G4: n. 2 ( d l . E i g h t P a t i e n t s (4$. 4 d ) were i n i t i a l l y t r e a t e d w i t h surgery, 7 o f them ( 3 Y . 4 6 ) w i t h a p e r s i s t e n t hyperprolactinemia r e q u i r e d Bromoc r i p t i n e (BEC) a f t e r surgery.
In 5 cases ( 4 % . lo") BEC c o n s t i t u t e d t h e primary treatment. b u t 1 y ~7 t h f a i l u r e t o BEC therapy needed transsphenoidal adenomectomy.
Follow-up was p o s s i b l e i n 11 p a t i e n t s . Among those who underwent surgery, 1 $ r ecovered gonadal f u n c t i o n spontaneously and 5 cases ( 3 ? . 2 6 ) r e q u i r e d complement a r y medical treatment. Among those t r e a t e d i n i t i a l l y w i t h BEC l t recovered menses spontaneously. 1 P needed progesterone therapy, 1 0 d i d n o t achieve normal PRL values a f t e r 9 m o f treatment, the adolescent who r e q u i r e d surgery had normal PRL l ev e l s w i t h o u t menses and t h e g r e c o v e r e d gonadal f u n c t i o n . I n conclusion: -Basal PRL l e v e l s seem t o be the most r e l e v a n t element i n h t e diagnosis o f prolactlnomas.
-C l i n i c a l t r i a l s would suggest an increase I " tumoral growth v e l o c i t y i n males.
-I n p e d i a t r i c p a t i e n t s . BEC appears as a u s e f u l resource f o r p r i m a r y o r complementary treatment o f prolactinomas.
